Dose concept of oncological hyperthermia: Heat-equation considering the cell destruction

Journal of Cancer Research and Therapeutics

Volumn 2, Issue 4, 2006, Pages 171-181

  Szasz, A ^a   Vincze, Gy ^b  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b NONE

Author keywords

Cell destruction; Dose of hyperthermia; Oncothermia; Pennes equation

Indexed keywords

EID: 33846567455     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.29827     Document Type: Article

References (87)

1. Senior K. NASA and NCI join forces to work on biomolecular sensors. Lancet Oncol 2001;2:328.
2. Overgaard J. Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis. Cancer 1977;39:2637-46.
3. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996;12:3-20.
4. Kitamura K, Kuwano H, Watanabe M, Nozoe T, Yasuda M, Sumiyoshi K, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995;60:55-8.
5. Egawa S, Tsukiyama I, Watanabe S, Ohno Y, Morita K, Tominaga S, et al. A randomized clinical trial of hyperthermia and radiation versus radiation alone for superficially located cancers. J Jpn Soc Ther Radiol Oncol 1989;1:135-40.
6. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomized, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-25.
7. Emami B, Scott C, Perez CA, Asbell S, Swift P, Grigsby P, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys 1996;34:1097-104.
8. Issels R. Hyperthermia combined with chemotherapy - biological rationale, clinical application and treatment results. Onkologie 1999;22:374-81.
9. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487-97.
10. Dewhirst MW, Sneed PK. Those in gene therapy should pay closer attention to lessons learnt from hyperthermia. Int J Radiat Oncol Biol Phys 2003;57:597-600.
11. van der Zee J, Hulshof MC. Lessons learned from hyperthermia. Int J Radiat Oncol Biol Phys 2003;57:597-600.
12. van der Zee J. Heating the patient: A promising approach? Ann Oncol 2002;13:1137-84.
13. Nielsen OS, Horsman M, Overgaard J. A future for hyperthermia in cancer treatment? Eur J Cancer 2001;37:1587-9.
14. Dewhirst MW. Thermal dosimetry. In: Thermo-radiotherapy and thermo-chemotherapy, vol.1. Biology, Physiology and Physics. Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Springer Verlag: Berlin Heidelberg; 1995. p. 123-36.
15. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948;1:93-122.
16. McRae DA, Esrick MA, Mueller SC. Non-invasive, in-vivo electrical impedance of EMT-6 tumors during hyperthermia: Correlation with morphology and tumour-growth delay. Int J Hyperthermia 1997;13:1-20.
17. McRae DA, Esrick MA, Mueller SC. Changes in the non-invasive, in vivo electrical impedance of the xenograpfts during the necrotic cell-response sequence. Int J Radiat Oncol Biol Phys 1999;43:849-57.
18. Vaupel P, Kallinowski FP. Blood flow, oxygen and nutrient supply and microenvironment of human tumors: A review. Cancer Res 1989;49:6449-65.
19. Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605-12.
20. Song CW, Lokshina A, Rhee JG, Patten M, Lewitt SH. Implication of blood-flow in hyperthermic treatment of tumors. IEEE Trans Biomed Eng 1984;31:9-16.
21. Song CW, Choi IB, Nah BS, Sahu SK, Osborn JL. Microvasculature and persfusion in normal tissues and tumors, thermoradiometry and thermochemotherapy. Seegenschmiedt MH, Fessenden P, Vernon CC, editors. 1995. p. 139-56.
22. Wallach DF. Action of Hyperthermia and Ionizing radiation on plasma membranes. In: Cancer therapy by hyperthermia and radiation. Streffer C, vanBeuningen D, Dietzel F, Rottingen E, Robinson JE, Scherer E, Seeber S, Trott KR, editors. Urban and Schwarzenberg: Baltimore, Munich; 1978. p.19-28.
23. Nishida T, Akagi K, Tanaka Y. Correlation between cell killing effect and cell-membrane potential after heat treatment: Analysis using fluorescent dye and flow cytometry. Int J Hyperthermia 1997;13:227-34.
24. Weiss TF. Cellular biophysics. Vol.1. Transport. MIT Press: Cambridge; 1996.
25. Dewhirst MW, Ozimek EJ, Gross J, Cetas TC. Will hyperthermia conquer the elusive hypoxic cell? Implications of heat effects on tumor and normal-tissue microcirculation. Radiology 1980;137:811-7.
26. Vaupel PW, Kelleher DK, Metabolic status and reaction to heat of Normal and tumor tissue, Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Thermo-radiotherapy and Thermo-chemiotherapy. Vol. 1. Biology, physiology and physics. Springer Verlag: Berlin Heidelberg; 1996. p. 157-76.
27. Heilbrunn LV. The colloid chemistry of protoplasm. Am J Physiol 1924;69:190-9.
28. Yatvin MB, Dennis WH. Membrane lipid composition and sensitivity to killing by hyperthermia, Procaine and Radiation. In: Cancer therapy by hyperthermia and radiation. Streffer C, vanBeuningen D, Dietzel F, Rottingen E, Robinson JE, Scherer E, Seeber S, Trott KR, editors. Urban and Schwarzenberg: Baltimore, Munich; 1978. p. 157-9.
29. Streffer C. Biological Basis of Thermotherapy (with special reference to Oncology). In: Biological basis of oncologic thermotherapy. Gautherie M, editor. Springer Verlag: Berlin; 1990. p. 1-72.
30. Bowler K. Cellular heat injury: Are membranes involved? Symp Soc Exp Biol 1987;41:157-85.
31. Belehradek J. Physiological aspects of heat and cold. Am Rev Physiol 1957;19:59-82.
32. Weiss TF. Cellular biophysics. Vol.2. Electrical properties. MIT Press: Cambridge; 1996.
33. Mikkelsen RB, Verma SP, Wallach DF. Hyperthermia and the membrane potential of erythrocyte membranes as studied by Raman Spectroscopy. In: Cancer therapy by hyperthermia and radiation. Streffer C, vanBeuningen D, Dietzel F, Rottingen E, Robinson JE, Scherer E, Seeber S, Trott KR, editors. Urban and Schwarzenberg: Baltimore, Munich; 1978. p. 160-2.
34. Hahn GM. The heat-shock response: Effects before, during and after Gene activation. In: Biological basis of oncologic thermotherapy. Gautherie M, editor. Springer verlag: Berlin; 1990. p. 135-59.
35. Hodgkin AL, Katz B. The effect of temperature on the electrical activity of the giant axon of the squid. J Physiol 1949;108:37-77.
36. Esrick MA, McRae DA. The effect of hyperthermia induced tissue conductivity changes on electrical, impedance temperature mapping. Phys Med Biol 1994;39:133-44.
37. Miklavcic D, Pavselj N, Hart FX. Electric properties of tissues. Wiley Encyclopedia of Biomedical Engineering. John Wiley and Sons Inc: 2006.
38. Jorritsma JB, Burgman P, Kampinga HH, Konings AW. DNA polymerase activity in heat killing and hyperthermic radiosensation of mammalian cells as observed after fractioned heat treatments. Radiat Res 1986;105:307-19.
39. Keszler G, Csapo Z, Spasokoutskaja T, Sasvary-Szekely M, Virga S, Demeter A, et al. Hyperthermy increase the phosporylation of deoxycytidine in the membrane phospholipid precursors and decrease its incorporation into DNA. Adv Exp Med Biol 2000;486:33-7.
40. Dikomey E, Franzke J. Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells. Int J Radiat Biol 1992;61:221-33.
41. Okumura Y, Ihara M, Shimasaki T, Takeshita S, Okaichi K. Heat inactivation of DNA-dependent protein kinase: Possible mechanism of hyperthermic radiosensitization. thermotherapy for neoplasia, Inflammation and pain. Kosaka M, Sugahara T, Schmidt KL, Simon E, editor. Springer Verlag: Tokyo; 2001. p. 420-3.
42. Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolorence and their relevance to clinical hyperthermia. Int J Hyperthermia 1995;11:459-88.
43. Soti C, Csermely P. Molecular chaperones in the etiology and therapy of cancer. Pathol Oncol 1998;4:316-21.
44. Ferrarini M, Heltai S, Zocchi MR, Rugarli C. Unusual expression and localization of heat shock proteins in human tumor cells. Int J Cancer 1992;51:613-9.
45. Protti MP, Heltai S, Bellone M, Ferrarini M, Manfredi AA, Rugarli C. Constitutive expression of the heat shock protein 72kDa in human melanoma cells. Cancer Lett 1994;85:211-6.
46. Gress TM, Muller-Pillasch F, Weber C, Lerch MM, Friess H, Buchler M, et al. Differenctial expression of heat shock proteins in pancreatic carcinoma. Cancer Res 1994;54:547-51.
47. Punyiczki M, Fesus L. Heat shock and apoptosis: The two defense systems of the organisms may have overlapping molecular elements. Ann NY Acad Sci 1998;851:67-74.
48. Huot J, Roy G, Lambert H, Landry J. Co-induction of HSP27 phosphorylation and drug resistance in Chinese hamster cells. Int J Oncol 1992;1:31-6.
49. Goodman R, Blank M. The induction of stress proteins for cytoprotection in clinical applications, First International Symposium on Nonthermal Medical/Biological Treatments Using Electromagnetic Fields and Ionized Gases, ElectroMed'99. Symposium Record Abstracts. Norfolk VA, USA; 1999. p. 57.
50. nd International Workshop on the Biological Effects of EMFs. Kostarakis P, editor. 2002. p. 394-403.
51. Sapozhnikov AM, Ponomarev ED, Tarashenko TN, Telford WG. Spontaneous apoptosis and expression of cell-surface het-shock proteins in cultured EL-4 lymphoma cells. Cell Prolif 1999;32:363-78.
52. Hupp TR, Meek DW, Midgley CA, Lane DP. Regulation of the specific DNA binding function of p53. Cell 1992;71:875-86.
53. Chen CF, Chen Y, Dai K, Chen PL, Riley DJ, Lee WH. A new member of the HSP90 Family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol 1996;16:4691-9.
54. Liu J. Temperature monitoring and heating optimization in cancer hyperthermia. Prog Nat Sci 2000;10:10.
55. Deng ZS, Liu J. Analytical study on bioheat transfer problems with spatial or transient heating on skin surface or inside biological bodies. Transactions of the ASME, Vol. 124, December 2002.
56. Wren J, Karlsson M, Loyd D. A hybrid equation for simulation of perfused tissue during thermal treatment. Int J Hyp 2001;17:483-98.
57. Davalos RV, Rubinsky B, Mir LM. Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 2003;61:99-107.
58. Bagaria HG, Johnson DT. Transient solution to the bioheat equation and optimization for magnetic fluid hyperthermia treatment. Int J Hyp 2005;21:57-75.
59. Gao B, Langer S, Corry PM. Application of the time-dependent Green's function and Fourier transforms to the solution of the bioheat equation. Int J Hyp 1995;11:267-85.
60. Wissler EH. Pennes' 1948 paper revisited. J Appl Physiol 1998;85:35-41.
61. Nelson DA. Invited editorial on Pennes' 1948 paper revisited. J Appl Physiol 1998;85:2-3.
62. Charny CK, Weinbaum S, Levin RL. An evaluation of the Weinbaum-Jiji equation for normal and hyperthermic conditions. J Biomech Eng 1990;112:80-7.
63. Najarian S, Pashaee A. Improvement of the Pennes Equation in the analysis of heat transfer phenomenon in blood perfused tissues. Biomed Sci Instrum 2001;37:185-90.
64. Katchalsky A, Curran PF. Nonequilibrium thermodinamics in biophysics. Harvard University Press Cambridge: Massachusetts; 1967.
65. Anderson DA, Tannehill JC, Pletcher RH. Computational fluid mechanics and heat transfer. McGraw-Hill: Washington; 1984.
66. Lupis CH. Chemical thermodynamics of materials. Elsevier Science Publishing Co Inc: 1983.
67. Pilling MJ, Seakins PW. Reaction Kinetics, Oxford Science Publications. Oxford University Press: Oxford-NewYork-Tokyo; 1995.
68. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 1994;10:457-83.
69. Lindholm CE. Hyperthermia and radiotherapy. Ph.D. Thesis, Lund University: Malmo, Sweden; 1992.
70. Hafstrom L, Rudenstam CM, Blomquist E, Ingvar C, Jonsson PE, Lagerlof B, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J Clin Oncol 1991;9:2091-4.
71. Perez CA, Sapareto SA. Thermal dose expression in clinical hyperthermia and correlation with tumor response/control. Cancer Research 1984;44:4818s-25s.
72. Separeto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Oncol Biol Phys 1984;10:787-800.
73. Thrall DE, Rosner GL, Azuma C, Larue SM, Case BC, Samulsky T, et al. Using units of CEM43oC T90 local hyperthermia thermal dose can be delivered as prescribed. Int J Hyperthermia 2000;16:415-28.
74. Urano M. Thermochemotherapy: From in vitro and in vivo experiments to potential clinical application. In: Hyperthermia and oncology. Urano M, Douple E, editors. VSP Utrecht-Tokyo; 1994. p. 169-204.
75. Bhowmick P, Coad JE, Bhowmick S, Pryor JL, Larson T, De La Rosette J, et al. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int J Hyperthermia 2004;20:421-39.
76. Lindegaard JC. Winner of the Lund Science Award 1992. Thermosensitization induced by step-down heating. A review on heat-induced sensitization to hyperthermia alone or hyperthermia combined with radiation. Int J Hyperthermia 1992;8:561-86.
77. Hasegawa T, Gu YH, Takahashi T, Hasegawa T, Yamamoto I. Enhancement of hyperthermic effects using rapid heating. In: Thermotherapy for neoplasia, inflammation and pain. Kosaka M, Sugahara T, Schmidt KL, Simon E, editors. Springer Verlag: Tokyo-Berlin; 2001. p. 439-44.
78. van Rijn J, van den Berg J, Wiegant FA, van Wijk R. Timetemperature relationships for step-down heating in normal and thermotolerant cells. Int J Hyperthermia 1994;10:643-52.
79. Henle KJ, RotiRoti JL. Response of cultured mammalian cells to hyperthermia, in Hyperthermia and Oncology. Urano M, Douple E, editors. Vol.1. VSP, Utrecht: Tokyo; 1988. p. 57-82.
80. Konings AW. Interaction of heat and Radiation in vitro and in vivo. In: Thermo-radiotherapy and thermo-chemotherapy, vol.1. Biology, Physiology and Physics. Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Springer Verlag: Berlin Heidelberg; 1995. p. 89-102.
81. Leophold KA. Dewhirst MW, Samulsky TV, Dodge RK, Georg SL, Blivin JL, et al. Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys 1993;25:841-7.
82. Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, et al. A phase II trial testing the thermal dose parameter CEM43° T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. Int J Hyperther 2001;17:283-90.
83. Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005;11:5206-14.
84. Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale fro thermal therapy. Int J Hyperthermia 2005;21:779-90.
85. Field SB. Biological aspects of hyperthermia. In: Physics and technology of hyperthermia. Field SB, Franconi C, editors. NATO ASI Series, Martimus Nijhoff Publishers: Dordrecht, Boston; 1987. p. 19-53.
86. Delannoy J, LeBihan D, Hoult DI, Levin RL. Hyperthermia system combined with a magnetic resonance imaging unit. Med Phys 1990;17:855-60.
87. van Rhoon GC, Wust P. Introduction: Non-invasive thermometry for thermotherapy. Int J Hyperthermia 2005;21:489-95.